| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 12 |
| 1 | CARBOPLATIN | 10 |
| 2 | CISPLATIN | 10 |
| 3 | PEMBROLIZUMAB | 10 |
| 4 | FLUOROURACIL | 9 |
| 5 | FLUOROURACIL CREAM, 0.5% | 9 |
| 6 | METHOTREXATE SODIUM | 9 |
| 7 | NIVOLUMAB | 9 |
| 8 | PACLITAXEL | 8 |
| 9 | PACLITAXEL (AIBUMIN-BOUND) | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN HUMAN AND FIBRINOGEN | 3 | 0.0089 |
| 1 | BEVACIZUMAB-BVZR | 2 | 0.0028 |
| 2 | TEPOTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 3 | LEVOLEUCOVORIN | 3 | 0.0008 |
| 4 | PSYLLIUM HUSK | 1 | 0.0007 |
| 5 | LEVOLEUCOVORIN INJECTION | 2 | 0.0007 |
| 6 | CERITINIB | 1 | 0.0004 |
| 7 | REMIFENTANIL HYDROCHLORIDE | 1 | 0.0004 |
| 8 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| 9 | SALINE NASAL SPRAY | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 3 | 0.0036 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 21 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 25 | 0.0001 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 14 | 0.0001 |
| 7 | Microtubule Inhibitor [EPC] | 10 | 0.0001 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 7 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |